Supplier Type
- Manufacturer
- contract manufacturer
- custom synthesis
- Trader
- Reagent
Supplier Region
- Maharashtra(123)
- Telangana(104)
- New Delhi(10)
- Hyderabad(39)
- Gujarat(124)
- Ahmedabad(5)
- Haryana(6)
- AndhraPradesh(6)
- Mumbai(23)
- Karnataka(9)
- Kerela(1)
- Bangalore(2)
- Madhya Pradesh(2)
- Uttar Pradesh(8)
- GOA(1)
- Tamil Nadu(9)
- West Bengal(3)
- Punjab(2)
- Andhra Pradesh(1)
- Vadodara(1)
- Rajasthan(2)
Purity
- NLT-98%
- API Standards
- 99.93
- 99.45
- 99% and above
- 99%
- 98+
- 98.5%
- 98%+
- 98% to 99%
- 98%
- >98%
- 97%
- 95%
- 90 % Above
- 0.98
Package
- 0As per requirement
- 0MT
- 0Std Packing
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 5gm
- 10gm
- 10g
- 25gm
- 25g
- 50g
- 100gm
- 25125kg and 1Mt
- 1001100 kg and 1 MT
- 2550025kg and 500 kg
- 100g
- 255025kg in 50litre HDPE drum
- 500g
- 1kg
- 5kg
- 10kg
- 20KG
- 25kg
- 50kg
- 100kg
- 500kg
- 1000kg
- 1grms kgs amd MT
- 1grms kgs and MT
- 1 kg
- 10 kg
- 10mt
- 25kgs
- 25Kg Fiber Drums
- 50kgs
- 255025 to 50 kg
- 111kg or above 1kg needs enquiry
- 50010500 mg and 1.0 gm
- 1001100mg and 1 g
- 25125kg and 1 MT
- 1MT
- 5 kg
- 25kgs fiber /hdpe drums
-
Lenalidomide
191732-72-6
-
CC 5013 hydrochloride
1243329-97-6
-
Dorzolamide N-Acetyl Impurity
403848-09-9
-
Methyl 2-[N-(tert-Butoxycarbonyl)-N-[(2'-cyanobiphenyl-4-yl)Methyl]aMino]-3-nitrobenzoate
139481-38-2
-
Mirabegron Impurity
1684452-83-2
-
Olmesartan Medoxomil Impurity 4
95579-71-8
-
Cabergoline Impurity B
166533-36-4
-
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol
274693-26-4
-
(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid
1246616-73-8
-
4-Chloro Bupropion FuMarate
1193779-36-0
4-Methylidenepiperidine hydrochloride 144230-50-2
Methyl 4-toluenesulfonate 80-48-8
4-(Aminomethyl)piperidine 7144-05-0
4-Methoxyphenylhydrazine hydrochloride 19501-58-7
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride 106261-49-8
